Brian Savage
Interim Chief Legal Officer · 4 filings · Latest: Sep 18, 2026
TEVA PHARMACEUTICAL INDUSTRIES LTD
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TEVA | Brian Savage | Interim Chief Legal Officer | Sep 18, 2026 | Sale | $38.85 | 7,342 | $285.2K | 8,500 | |
TEVA | Brian Savage | Interim Chief Legal Officer | Sep 18, 2026 | Option Exercise | $34.70 | 4,503 | $156.3K | 15,842 | |
TEVA | Savage Brian | — | Sep 18, 2026 | Proposed Sale | $38.85 | 7,028 | $273.1K | — | |
TEVA | Brian Savage | Interim Chief Legal Officer | Mar 5, 2026 | Sale | $31.67 | 1,127 | $35.7K | 10,914 | |
TEVA | Brian Savage | Interim Chief Legal Officer | Mar 5, 2026 | Option Exercise | — | 3,580 | — | 12,041 | |
TEVA | Brian Savage | Interim Chief Legal Officer | Mar 4, 2026 | Sale | $32.46 | 2,675 | $86.8K | 8,461 | |
TEVA | Brian Savage | Interim Chief Legal Officer | Mar 4, 2026 | Option Exercise | — | 8,210 | — | 9,647 | |
TEVA | Savage Brian | — | Mar 5, 2026 | Proposed Sale | $31.67 | 1,127 | $35.7K | — | |
TEVA | Brian Savage | Interim Chief Legal Officer | Mar 3, 2026 | Sale | $32.36 | 1,274 | $41.2K | 2,926 | |
TEVA | Brian Savage | Interim Chief Legal Officer | Mar 3, 2026 | Option Exercise | — | 3,461 | — | 4,200 | |
TEVA | Savage Brian | — | Mar 3, 2026 | Proposed Sale | $32.36 | 1,274 | $41.2K | — |